Medical technology platform Inito has secured $6 mn in a Series A funding round led by Fireside Ventures.
The business plans to utilise the additional funding to advance the hormone test’s global expansion, enhance its analytics through the use of artificial intelligence (AI), and support research and development for other tests.
“The partnership with Fireside Ventures has not only provided crucial financial backing but also valuable mentorship and strategic guidance, enabling Inito to build a leading consumer health tech brand for the world from India,” cofounders of Inito, Aayush Rai and Varun AV said in a joint statement.
In the long run, the company wants to use a smartphone-based platform to provide diagnostic testing for a range of health issues.
Read also – Paytm Partners With Global Travel Technology Company Amadeus
With an 8X growth rate in 2022, Inito is expected to grow by over 4X in 2023 and be available in over ten countries by 2024.
The only hormone monitoring tool that analyses all four reproductive hormones reliably is the Inito reproductive Monitor. More than 20,000 couples in the US and India trust it. The greatest investors in the world, including Y Combinator and numerous more from the US, Singapore, and India, support Inito.
About Inito
With the goal of providing every home with the newest health trackers, Inito aims to make wellness and healthcare easier. The most sophisticated and user-friendly biomarkers available power their products, guiding you through every stage of your health journey.
Read also – [Funding alert] Keychain Secures $18 Mn Seed Funding Led by Lightspeed
